Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

Conditions

Acute Coronary Syndrome

Keywords

Long-term follow up, Antithrombotic management patterns, Acute Coronary Syndrome, Asia, quality of life

Brief summary

The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.

Huo Y, Van de Werf F, Han Y, Rossello X, Pocock SJ, Chin CT, Lee SW, Li Y, Jiang J, Vega AM, Medina J, Bueno H.

2021-02-044 citations

10.1007/s40256-020-00447-5

Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study.

Zhou J, Chin CT, Huang X, Guo N, Wu Y, Yu B, Qiao S, Chen J, Han Y, Ge J, Pocock SJ, Huo Y, Wang Z, Yuan Z.

2020-11-101 citations

10.1016/j.ijcard.2020.11.015

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long‐Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study

Shao-yi Guan, Xiao‐Ming Xu, Yi Li, Jing Li, Mingzi Guan et al. (9 authors)

Journal of the American Heart Association2020-11-074 citations

10.1161/jaha.119.013476

Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the <scp>EPICOR</scp> Asia study

Bo Zheng, Yong Huo, Stephen W.L. Lee, J.P.S. Sawhney, Hyo‐Soo Kim et al. (15 authors)

Clinical Cardiology2020-07-027 citations

10.1002/clc.23400

Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia.

Zhang S, Wang W, Sawhney JPS, Krittayaphong R, Kim HS, Nhan VT, Lee SW, Ong TK, Chin CT, Pocock SJ, Huo Y, Qian J, Ge J.

2020-03-1716 citations

10.1016/j.ijcard.2020.01.008

Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia.

Jan S, Lee SW, Sawhney JPS, Ong TK, Chin CT, Kim HS, Krittayaphong R, Nhan VT, Pocock SJ, Vega AM, Hayashi N, Huo Y.

2018-07-0413 citations

10.1186/s12872-018-0859-4

Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: Insights from the multinational EPICOR Asia study.

Chin CT, Ong TK, Krittayaphong R, Lee SW, Sawhney JPS, Kim HS, Garcia AA, Bueno H, Pocock SJ, Nhan VT, Vega A, Hayashi N, Huo Y.

2017-09-0114 citations

10.1016/j.ijcard.2017.04.059

Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score.

Pocock SJ, Huo Y, Van de Werf F, Newsome S, Chin CT, Vega AM, Medina J, Bueno H.

2017-08-0431 citations

10.1177/2048872617719638

Abstract 15408: Long-term Antithrombotic Management Patterns After Acute Coronary Syndromes: 2-[[Unsupported Character - Codename &shy;]]years Follow-up in the EPICOR Asia Study

Yong Huo, Stephen W Lee, J.P.S. Sawhney, Hyo‐Soo Kim, Rungroj Krittayaphong et al. (12 authors)

Circulation2015-11-10

10.1161/circ.132.suppl_3.15408

Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia).

Huo Y, Lee SW, Sawhney JP, Kim HS, Krittayaphong R, Nhan VT, Alonso-Garcia A, Han YL, Ge J, Chin CT, Ong TK, Jan S, Itoh Y, Vega AM, Pocock S.

2015-07-2427 citations

10.1002/clc.22431

ASSA14-01-06 One-year outcomes in Chinese patients with acute coronary syndromes: a subanalysis of EPICOR Asia study

Yong Huo, YL Han, Ge Jb, Jy Chen, ZY Yuan et al. (7 authors)

2014-12-011 citations

10.1136/heartjnl-2014-307109.6

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study.

Pocock S, Bueno H, Licour M, Medina J, Zhang L, Annemans L, Danchin N, Huo Y, Van de Werf F.

2014-10-0956 citations

10.1177/2048872614554198

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* Written informed consent has been provided. * Diagnosis of STEMI, NSTEMI or UA * Hospitalization for the first time within 48 hours of onset of symptoms.

Exclusion criteria

* UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons. * Current participation in a randomised interventional clinical trial.

Design outcomes

Primary

Measure	Time frame
short- and long-term medication and treatment prescribed by physicians in real-life setting	up to 3 years

Secondary

Measure	Time frame
clinical outcome (Cardiovascular events)	up to 3 years
cost of hospitalization	up to 3 years
quality of life (EQ-5D questionnaire)	up to 3 years

Countries

China, India, Malaysia, Singapore, South Korea, Thailand, Vietnam

Outcome results